Uptrend on the daily chart: above its 50- and 200-day averages · 50-day above the 200-day · SuperTrend up since Feb 24 · inside the Ichimoku cloud · RSI 74 (overbought) · MACD below its signal · at its 52-week high
None of the 29 investors followed here reported a position in NOUV in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a NOUV trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for NOUV.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% | ||
| 2025 | 0.0 | 0.0 | 100.0 | -50.0 | 0.0 | 0.0 | 0.0 | 0.0 | -90.0 | 0.0 | 900.0 | 0.0 | −0.0% |
| 2024 | 0.0 | -33.3 | 0.0 | 0.0 | 0.0 | -50.0 | 100.0 | 0.0 | -50.0 | 100.0 | -50.0 | 0.0 | −66.7% |
| 2023 | 0.0 | -40.0 | 100.0 | -33.3 | 25.0 | -28.0 | 11.1 | 0.0 | 0.0 | 0.0 | 0.0 | 50.0 | +20.0% |
| 2022 | -33.3 | -20.0 | 25.0 | -25.0 | -46.7 | 75.0 | -21.4 | -27.3 | -12.5 | -28.6 | 20.0 | -16.7 | −83.3% |
| 2021 | 150.0 | 60.0 | -25.0 | 33.3 | -25.0 | 33.3 | 112.5 | -41.2 | 180.0 | -21.4 | -45.5 | 25.0 | +650.0% |
| 2020 | -33.3 | 0.0 | -50.0 | 0.0 | 0.0 | 0.0 | 100.0 | -50.0 | 0.0 | 100.0 | 0.0 | 0.0 | −33.3% |
| 2019 | -42.9 | -25.0 | -16.7 | 20.0 | -16.7 | -20.0 | 0.0 | -25.0 | 0.0 | 0.0 | -33.3 | 50.0 | −78.6% |
| 2018 | 0.0 | -50.0 | 0.0 | 20.0 | -16.7 | 0.0 | 0.0 | 0.0 | 100.0 | 100.0 | -50.0 | 600.0 | +600.0% |
| 2017 | 1525.0 | -67.3 | 123.5 | -13.2 | -30.3 | -60.9 | -77.8 | -50.0 | 0.0 | 100.0 | -50.0 | 100.0 | −37.5% |
| 2016 | 0.0 | 0.0 | -66.7 | 0.0 | 100.0 | 10.0 | -9.1 | 0.0 | 0.0 | 50.0 | 33.3 | -20.0 | +6.7% |
| 2015 | 0.0 | 0.0 | 0.0 | -25.0 | 0.0 | 0.0 | -33.3 | 0.0 | 50.0 | 0.0 | 0.0 | 0.0 | −25.0% |
| 2014 | 66.7 | 0.0 | 0.0 | 40.0 | 14.3 | -50.0 | 50.0 | -16.7 | 0.0 | 0.0 | 0.0 | -20.0 | +33.3% |
| 2013 | 15.0 | 8.7 | -52.0 | 16.7 | -35.7 | -11.1 | -37.5 | 0.0 | -40.0 | 66.7 | -20.0 | -25.0 | −85.0% |
| 2012 | 125.8 | -7.1 | -55.8 | -13.0 | -3.0 | -53.6 | -37.8 | 3.6 | -25.9 | -30.2 | 0.0 | -33.3 | −91.9% |
| 2011 | 40.0 | -28.6 | 50.0 | 113.3 | -49.4 | 23.5 | 90.0 | -21.1 | -16.7 | 19.2 | 34.2 | 24.0 | +396.0% |
| 2010 | 185.7 | 0.0 | 7.3 | -25.5 | -37.5 | 0.0 | 0.0 | -26.7 | -9.1 | -20.0 | -25.0 | -16.7 | −52.4% |
| 2009 | -20.0 | 0.0 | -75.0 | 400.0 | -30.0 | 214.3 | -27.3 | 0.0 | -12.5 | 0.0 | -14.3 | -82.5 | −79.0% |
| 2008 | -20.9 | 0.0 | 0.0 | 5.9 | 16.7 | 0.0 | -33.3 | -14.3 | -8.3 | -72.7 | 33.3 | 25.0 | −76.7% |
| 2007 | -28.9 | 40.7 | 10.5 | -7.1 | -25.6 | 6.9 | -3.2 | -26.7 | 13.6 | -12.0 | 13.6 | -14.0 | −43.4% |
No analyst coverage for this instrument.
Nouveau Life Pharmaceuticals, Inc., a development stage company, engages in providing a platform for remote senior care. The company also enables users to monitor patients in real time and access detailed patient information digitally; and its platform is designed to detect emergencies proactively and facilitate non-face-to-face care services. In addition, the company is developing robotic and artificial intelligence (AI)-based healthcare devices and wearables. The company was formerly known as Gondwana Energy, Ltd. and changed its name to Nouveau Life Pharmaceuticals, Inc. in May 1998. The company was incorporated in 1998 and is based in Los Angeles, California. Nouveau Life Pharmaceuticals, Inc. operates as a subsidiary of Seniorgo.ai.
No recent headlines.